Cloud-Based Patient-Reported Outcomes

Concerto HealthAI’s powerful Patient Care Monitor (PCM) seamlessly integrates into clinical practice workflows to create clinical utility and capture and act on patient-reported outcomes (PRO) in real time, from diagnosis through survivorship:

  • Monitor and track patient symptoms at the point of care and in between visits with a validated Core Symptom Survey
  • Export PRO data automatically to any EMR
  • Receive real-time reports and alerts as changes occur in health status
  • Help meet reporting requirements of organizations and alternative payment models such as QOPI, OCM, CoC and MIPS.

Monitoring and tracking patient symptoms with the use of ePRO tools can improve clinical and quality outcomes, create quality metric reporting efficiencies, as well as reduce clinic burden and lower the cost of care.1, 2, 3

Research Published in 2019 ASCO Annual Meeting

Understanding patient advance directives status in a community oncology practice using an electronic patient-reported outcomes (ePRO) system.

READ THE FULL ABSTRACT

Example Topics from Our Comprehensive Survey Library

  • Complete Review of Systems (eg: Core Symptom Survey)
  • Psychosocial Distress Screening (eg: PHQ2, PHQ9)
  • Tobacco Use Screening and History
  • CAHPS Oncology Patient Satisfaction/Experience Survey
  • ECOG Assessment
  • Falls Risk Assessment
  • Learning Needs Assessment
  • Quality of Life (eg: FACT)
  1. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017 Jul 11; 318(2): 197-198.
  2. Basch E, Allison MD, Mark GK, Howard IS, Clifford AH, Paul S, (2015). Symptom Monitoring With Patient- Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial, J Clin Oncol 2016: 34(6), 557–565.
  3. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. J Clin Oncol 2004; 22: 714– 724.